Jaguar Health, Inc.
For the period ended Jun 30, 2025. Filed Aug 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 14, 2025
JAGX$0.44+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Losses
| Three Months Ended · Six Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|
| June 30, · June 30, | ||||||||
| (In thousands, except share and per share data) · 2025 · 2024 · 2025 · 2024 | ||||||||
| Net loss | $ | (10,560) | $ | (9,628) | $ | (21,156) | $ | (18,996) |
| Other comprehensive loss (gain) | (22) | (94) | (285) | 124 | ||||
| Net comprehensive loss | $ | (10,582) | $ | (9,722) | $ | (21,441) | $ | (18,872) |
| Common stockholders: | ||||||||
| Net loss attributable to common stockholders | $ | (10,407) | $ | (9,492) | $ | (20,871) | $ | (18,718) |
| Other comprehensive loss attributable to common stockholders | ||||||||
| Translation adjustments | (19) | (82) | (253) | 110 | ||||
| Net comprehensive loss attributable to common stockholders | $ | (10,426) | $ | (9,574) | $ | (21,124) | $ | (18,608) |
| Noncontrolling interests: | ||||||||
| Net loss attributable to noncontrolling interests | $ | (153) | $ | (136) | $ | (285) | $ | (278) |
| Other comprehensive loss attributable to noncontrolling interests | ||||||||
| Translation adjustments | (3) | (12) | (32) | 14 | ||||
| Net comprehensive loss attributable to noncontrolling interests | $ | (156) | $ | (148) | $ | (317) | $ | (264) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.